We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Thermo Fisher and Ford Partner to Scale Production of Collection Kits for COVID-19 Tests

By LabMedica International staff writers
Posted on 17 Apr 2020
Thermo Fisher Scientific Inc. (Waltham, MA, USA) has tied up with The Ford Motor Company (Dearborn, MI, USA) for manufacturing support to help it quickly expand the production of COVID-19 collection kits for patient testing.

Ford is expanding its efforts to design and produce urgently needed medical equipment and supplies for health care workers, first responders and patients fighting coronavirus. Ford, with design and testing consultation from 3M, has developed a new powered air-purifying respirator (PAPR). It has commenced production of this PAPR and has the ability to make 100,000 or more units. Ford is also collaborating with the UAW for producing face masks for internal use globally and pursuing certification for medical use. To help further protect health care workers, Ford is leading efforts to manufacture reusable gowns from airbag materials with supplier Joyson Safety Systems.

Illustration
Illustration

Additionally, Ford is lending its manufacturing support to help Thermo Fisher Scientific quickly expand its production of COVID-19 collection kits for patient testing. Thermo Fisher’s engineering team at the company’s site in Lenexa, Kansas, is combining their expertise with the manufacturing expertise of Ford’s nearby Kansas City Assembly Plant engineering team, to set up additional collection kit production machinery. The Ford team has also helped Thermo Fisher adapt machinery that currently runs glass vials for other products to run plastic vials required in drive-through coronavirus test collection.

“Ford's engineers brought a fresh perspective to production expansion, and together, we'll more than triple the number of collection kits we can deliver each week starting April 20,” said John Reuss, senior director, microbiology business for Thermo Fisher. “It’s great to see different industries coming together to solve a common problem."



New
Gold Member
ANA & ENA Screening Assays
ANA and ENA Assays
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Nuclear Matrix Protein 22 Test
NMP22 Test
New
Human Insulin CLIA
Human Insulin CLIA Kit

Latest COVID-19 News

New Immunosensor Paves Way to Rapid POC Testing for COVID-19 and Emerging Infectious Diseases

Long COVID Etiologies Found in Acute Infection Blood Samples

Novel Device Detects COVID-19 Antibodies in Five Minutes